{"originalText": "，于3年前行直肠癌LAR术，PT4AN1M0, 术后行FOLFOX6化疗*12\\U0004\\U0004 2011.3气短，两肺M，KRAS WT,CEA化疗前5.97，2011-3-23开始XELOX化疗4周期,复查缩小SD,气短减轻。胆红素2度升高，停止OXA（2011-6中旬），化疗延迟2周余，胸闷略有加重，CEA 6.9。 \\U0004\\U0004 2011.6.29继续XELODA，服药期间觉胸闷好转，停药的1周内觉气短。，2012-1-10CT:肺病灶增大SD，因XELODA控制症状尚可,继服1周期后,胸闷加重,CEA 5.4.\\U0004\\U0004  2012-2-6起行XELOX6周期，耐受好，胸闷明显好转, ，3周期后CT：SD（略增大），但CEA稳定，症状获益，末次2012.5.13。手足麻木I度，此次消化道反应2度，较前加重，现恢复 \\U0004\\U0004   6，周期评效：，CEA：7.43，浅表淋巴结较前变化不大。胸部，CT：两肺多发结节同前，左肺上叶略增大。纵隔淋巴结同前。腹部CT未见新生占位。\\U0004\\U0004现觉胸闷明显好转，睡眠、饮食可，大小便可，体重无变化。", "entities": [{"end_pos": 13, "label_type": "手术", "overlap": 0, "start_pos": 6}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 157, "end_pos": 160}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"label_type": "影像检查", "overlap": 0, "start_pos": 227, "end_pos": 229}, {"end_pos": 231, "label_type": "解剖部位", "overlap": 0, "start_pos": 230}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 264, "end_pos": 267}, {"end_pos": 310, "label_type": "解剖部位", "overlap": 0, "start_pos": 309}, {"label_type": "影像检查", "overlap": 0, "start_pos": 322, "end_pos": 324}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 334, "end_pos": 337}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 406, "end_pos": 409}, {"label_type": "影像检查", "overlap": 0, "start_pos": 427, "end_pos": 432}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 433}, {"end_pos": 446, "label_type": "解剖部位", "overlap": 0, "start_pos": 442}, {"end_pos": 455, "label_type": "解剖部位", "overlap": 0, "start_pos": 450}, {"label_type": "影像检查", "overlap": 0, "start_pos": 458, "end_pos": 462}, {"end_pos": 484, "label_type": "解剖部位", "overlap": 0, "start_pos": 483}]}
